NPI registry status
Active
2026 NPPES data Allergy & Immunology Physician NPI 1689681439 MD
Verify on CMS → Richard Ando, MD
Allergy & Immunology Physician in Honolulu, Hawaii.
This profile is drawn from the federal National Provider Identifier Registry (CMS NPPES), which lists more than 7 million U.S. healthcare providers - including 3,412 in Allergy & Immunology Physician, and covers specialty classification, practice address, and Medicare Part D prescribing data when reported. According to CMS, every field reflects the provider's official federal registration, see our methodology.
Federal data, no proprietary rating.
We show these CMS records as-is - no composite score, no star rating, no editorial opinion layered on top.
Prescribing volume
448
Medicare Part D claims · 64 beneficiaries · Allergy & Immunology Physician avg: 788
Generic prescribing
58%
generic claims · 42% brand-name · higher generic rates reduce patient out-of-pocket costs
Industry payments
$689.89
26 payments · CMS Open Payments (Sunshine Act)
Source: CMS Medicare Part D Prescriber Public Use File, 2024
What the federal data shows
Richard Ando, MD filed 448 Medicare Part D claims in 2024 as an Allergy & Immunology Physician in Honolulu, Hawaii, prescribing 58% generic.
- 448
- Part D claims, 2024
- 58%
- generic prescribing
- $689.89
- industry payments (Sunshine Act)
- ≥61st
- pct by Part D claim volume (lower-bound band)
Every figure on this page comes straight from federal CMS records (NPPES, Medicare Part D, MIPS, Open Payments) - no proprietary rating or editorial opinion is applied.
Federal trust snapshot
What official records show about Richard Ando, MD
Federal records show an active NPI with Medicare Part D prescribing activity — verifiable registry data, not a proprietary rating.
- Verified
NPI registry status
Active listing in the CMS National Provider Identifier Registry (NPI 1689681439), first enumerated 08/02/2006.
Source: CMS NPPES
- Reported
Medicare Part D participation
Filed 448 Medicare Part D prescription claims in the 2023 CMS public use file — indicates active Medicare prescribing participation.
Source: CMS Part D Prescriber PUF
- Reported
Board certification signal
Practices in an ABMS-board-eligible specialty; board certification not confirmed in federal records.
- Reported
Industry payment transparency
$689.89 in reported industry payments (26 transfers) in 2024 under the federal Sunshine Act — disclosed transfers of value, not a quality rating.
Source: CMS Open Payments
- Not in federal data
Individual sanction lookup
PlainDoctor does not publish per-provider disciplinary determinations. Confirm current license and any individual actions through the state medical board or FSMB verification service.
Source: State medical board / FSMB
This trust snapshot summarizes only what appears in federal CMS/NPPES public records. It is not a composite score, star rating, patient review, or clinical recommendation. PlainDoctor never fabricates reviews or AggregateRating schema.
CMS NPPES provider registry desk
NPI 1689681439 · Allergy & Immunology Physician
NPI-10 · ENUM-LEGACY · TAX-NARROW · RX-LIGHT · BOOK-THIN · PHOTO-ENUM
- NPI-10 1689681439
- ENUM-LEGACY 2006
- TAX-NARROW 3,412
- RX-LIGHT 448
- BOOK-THIN 13 in Hawaii
- PHOTO-ENUM Paul Sutton · 2006
Richard Ando, MD's Medicare Part D volume vs every U.S. prescriber
Total Medicare Part D claims, 2024, across all CMS prescribers nationally
448 ≥ 61st percentile 61% of 1,416,883 prescribers are in lower value bands
Each bar is a band; taller bars hold more prescribers. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
The percentile is a conservative 100-claim band: it counts only prescribers in lower claim-volume bands. Medicare Part D claim volume is activity context, not a quality measure or recommendation. See methodology § corpus placement.
Source CMS Medicare Part D Prescriber Public Use File · 2024
◑
Board-eligible specialty (heuristic, not verified)
Richard Ando, MD practices in an ABMS-board-eligible specialty but we don't have enough CMS-participation signals to confirm active board-certified status. Consult CertificationMatters.org (the official ABMS public lookup).
What does the federal data show about Richard Ando, MD?
Quality data not reportedPrimary specialty
Allergy & Immunology Physician
Medicare Part D claims
448 43% vs specialty avg
Specialty distribution in Hawaii
How Allergy & Immunology Physician compares to other specialties among Hawaii providers
Board certification
Not published by CMS
CMS does not publish a per-provider board-certification field in NPPES. PlainDoctor does not have a reliable per-specialty certification rate to show for Allergy & Immunology Physician. Verify directly:
How MIPS and board certification work
The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.
Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).
Practice Address
Provider Details
| NPI | 1689681439 |
|---|---|
| Specialty | Allergy & Immunology Physician |
| Credentials | MD |
| Gender | Male |
| NPI Issued | 08/02/2006 |
Industry payments received (2024) - CMS Open Payments transparency data
The federal Physician Payments Sunshine Act (part of the Affordable Care Act) requires drug and medical-device manufacturers + group purchasing organizations to publicly report payments and other transfers of value to physicians and teaching hospitals. The data below covers 2024 for Richard Ando, MD. Source: openpaymentsdata.cms.gov.
Total received
$690
Largest payer
AstraZeneca Pharmaceuticals LP
Most common payment type
Food and Beverage
Industry payments are not necessarily indicators of bias, they include research funding, consulting fees for evidence-based work, royalties for inventions, food at conferences, and similar items. The disclosure exists for transparency. Read our methodology for how we interpret this data.
Brand vs generic prescribing mix · Above average
Richard Ando, MD - brand share 42.0%
Allergy & Immunology Physician average
42% brand-name claims vs 58% generic, on 448 2024 Medicare Part D claims.
The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.
Medicare Part D Prescribing Data
CMS Medicare Part D prescriber-level data for calendar year 2024.
448
Total Claims
$225K
Total Drug Cost
64
Medicare Beneficiaries
Prescribing Breakdown
- 30-Day Fills
- 829.667
- Total Day Supply
- 23,452
- Brand vs Generic
- 42% brand / 58% generic
- Brand Drug Cost
- $206K
- Generic Drug Cost
- $19K
Patient Demographics
- Average Patient Age
- 75.9 years
- Avg HCC Risk Score
- 1.01
- Gender Split
- 72% female / 28% male
- Age Distribution
- <65: 0, 65-74: N/A, 75-84: 32, 85+: N/A
Top Prescribed Drugs (Medicare Part D)
Top drugs by claim count for calendar year 2024. Based on Medicare Part D data only.
What Richard Ando, MD prescribes most
Top Medicare Part D drugs by claim count, 2024
- Albuterol Sulfate …
Albuterol Sulfate Hfa
54 claims
- Fluticasone Propio…
Fluticasone Propionate
42 claims
- Wixela Inhub
Wixela Inhub
37 claims
- Prednisone
Prednisone
24 claims
- Dupixent Syringe
Dupixent Syringe
23 claims
- Montelukast Sodium
Montelukast Sodium
23 claims
- Fluticasone Propio… 20
Fluticasone Propionate Hfa
20 claims
- Hydroxyzine Hcl 20
Hydroxyzine Hcl
20 claims
| Drug | Claims |
|---|---|
| Albuterol Sulfate Hfa Albuterol Sulfate | 54 |
| Fluticasone Propionate | 42 |
| Wixela Inhub Fluticasone Propion/Salmeterol | 37 |
| Prednisone | 24 |
| Dupixent Syringe Dupilumab | 23 |
| Montelukast Sodium | 23 |
| Fluticasone Propionate Hfa Fluticasone Propionate | 20 |
| Hydroxyzine Hcl | 20 |
| Desloratadine | 16 |
| Ipratropium Bromide | 16 |
* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.
Allergy & Immunology Physician Overview
How Richard Ando, MD fits within the Allergy & Immunology Physician landscape nationally.
3,412
Allergy & Immunology Physician Providers in US
52
States with Allergy & Immunology Physician
788
Avg Claims per Provider
Richard Ando, MD's 448 claims are below the specialty average of 788.
Nationwide Allergy & Immunology Physician peers with similar MIPS or enrollment year
Two federal-record peer sets for Ando, both outside Hawaii so the neighborhoods are not geographic containment.
Same NPPES enumeration year (2006)
Same-specialty clinicians who entered the NPI registry in the same calendar year, outside this state.
Nearby Allergy & Immunology Physician Providers in Hawaii
Other clinicians with the same primary specialty enrolled in Hawaii, drawn from the same CMS NPPES roster as Ando.
One of 13 Allergy & Immunology Physician providers enrolled in Hawaii, 5 are shown here.
Dr. Conrad Belnap
MD
Tamc, HI
Dr. George Chu
MD
Honolulu, HI
Dr. Abigail Harada
M.D.
Honolulu, HI
Dr. Philip Kuo
M.D., PH.D.
Kailua, HI
Dr. Philip Kuo
MD
Kailua, HI
Compare Allergy & Immunology Physician nationally: see state-by-state distribution →
Frequently Asked Questions
What is Richard Ando, MD's specialty? ▼
Richard Ando, MD specializes in Allergy & Immunology Physician and practices in Honolulu, Hawaii. Credentials: MD.
How much does Richard Ando, MD prescribe under Medicare Part D? ▼
In 2024, Richard Ando, MD wrote 448 Medicare Part D claims totaling $225K in drug costs for 64 beneficiaries.
Where is Richard Ando, MD located? ▼
Richard Ando, MD is located at 405 N KUAKINI ST, Honolulu, HI, 96817. Phone: (808) 538-1915.
What is Richard Ando, MD's NPI number? ▼
Richard Ando, MD's National Provider Identifier (NPI) is 1689681439, issued on 08/02/2006.
Does Richard Ando, MD prescribe more brand-name or generic drugs? ▼
Richard Ando, MD's prescribing is 42% brand-name and 58% generic drugs by claim count, with $206K in brand drug costs.
How many Allergy & Immunology Physician providers are there in the US? ▼
There are 3,412 Allergy & Immunology Physician providers across 52 states in the US. The average Allergy & Immunology Physician provider writes 788 Medicare Part D claims per year.
What drugs does Richard Ando, MD prescribe most often? ▼
Based on 2024 Medicare Part D data, Richard Ando, MD's most frequently prescribed drugs include Albuterol Sulfate Hfa, Fluticasone Propionate, Wixela Inhub. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does Richard Ando, MD accept Medicare? ▼
Richard Ando, MD appears in CMS Medicare data with 448 Part D claims and 64 Medicare beneficiaries in 2024. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify Richard Ando, MD's credentials? ▼
Richard Ando, MD's NPI is 1689681439 with credentials MD. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.
Data Sources
View source datasets and methodology notes
- Provider Directory
- CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
- Specialty Classification
- NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
- Prescribing Data
- CMS Medicare Part D Prescriber Public Use File (2024). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
- Limitations
- Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.
See our complete data methodology for details on how we collect and process government data.
Data as of August 2026 (NPPES) / 2024 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).
Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology
Every figure on PlainDoctor is rendered directly from the federal CMS NPPES registry, Medicare Part D, MIPS, and Open Payments records, no number is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of August 2026.